Clal Biotechnology Industries Ltd. (CBI.TA)
ILA 35.6
(-0.84%)
ILA 35.6
(-0.84%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 158.38 Million ILS | -13.3% |
| 2022 | 182.69 Million ILS | -58.94% |
| 2021 | 444.91 Million ILS | -27.54% |
| 2020 | 614.03 Million ILS | -0.48% |
| 2019 | 616.96 Million ILS | -39.28% |
| 2018 | 1.01 Billion ILS | -1.77% |
| 2017 | 1.03 Billion ILS | -7.54% |
| 2016 | 1.11 Billion ILS | -27.01% |
| 2015 | 1.53 Billion ILS | -9.17% |
| 2014 | 1.68 Billion ILS | -12.17% |
| 2013 | 1.92 Billion ILS | 9.83% |
| 2012 | 1.74 Billion ILS | 39.89% |
| 2011 | 1.25 Billion ILS | -8.32% |
| 2010 | 1.36 Billion ILS | 45.67% |
| 2009 | 936.32 Million ILS | 119.83% |
| 2008 | 425.92 Million ILS | 1.3% |
| 2007 | 420.47 Million ILS | 226.5% |
| 2006 | 128.78 Million ILS | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | 158.38 Million ILS | -18.77% |
| 2023 FY | 158.38 Million ILS | -13.3% |
| 2023 Q2 | 194.98 Million ILS | 0.0% |
| 2023 Q4 | 158.38 Million ILS | 0.0% |
| 2023 Q1 | 194.98 Million ILS | 6.73% |
| 2022 Q4 | 182.69 Million ILS | -3.27% |
| 2022 Q1 | 466.61 Million ILS | 4.88% |
| 2022 FY | 182.69 Million ILS | -58.94% |
| 2022 Q2 | 449.3 Million ILS | -3.71% |
| 2022 Q3 | 188.87 Million ILS | -57.96% |
| 2021 FY | 444.91 Million ILS | -27.54% |
| 2021 Q2 | 533.9 Million ILS | -14.8% |
| 2021 Q3 | 504.99 Million ILS | -5.42% |
| 2021 Q4 | 444.91 Million ILS | -11.9% |
| 2021 Q1 | 626.62 Million ILS | 2.05% |
| 2020 Q4 | 614.03 Million ILS | 11.61% |
| 2020 FY | 614.03 Million ILS | -0.48% |
| 2020 Q1 | 577.45 Million ILS | -6.4% |
| 2020 Q2 | 568.19 Million ILS | -1.6% |
| 2020 Q3 | 550.14 Million ILS | -3.18% |
| 2019 Q3 | 662.68 Million ILS | -7.99% |
| 2019 FY | 616.96 Million ILS | -39.28% |
| 2019 Q4 | 616.96 Million ILS | -6.9% |
| 2019 Q1 | 978.79 Million ILS | -3.67% |
| 2019 Q2 | 720.25 Million ILS | -26.41% |
| 2018 FY | 1.01 Billion ILS | -1.77% |
| 2018 Q4 | 1.01 Billion ILS | 2.01% |
| 2018 Q3 | 996.07 Million ILS | -0.38% |
| 2018 Q2 | 999.91 Million ILS | -1.12% |
| 2018 Q1 | 1.01 Billion ILS | -2.24% |
| 2017 Q1 | 1.04 Billion ILS | -6.44% |
| 2017 Q4 | 1.03 Billion ILS | -4.87% |
| 2017 Q3 | 1.08 Billion ILS | 9.72% |
| 2017 FY | 1.03 Billion ILS | -7.54% |
| 2017 Q2 | 990.93 Million ILS | -5.33% |
| 2016 Q3 | 1.33 Billion ILS | -6.06% |
| 2016 FY | 1.11 Billion ILS | -27.01% |
| 2016 Q2 | 1.41 Billion ILS | -1.68% |
| 2016 Q4 | 1.11 Billion ILS | -15.93% |
| 2016 Q1 | 1.44 Billion ILS | -6.0% |
| 2015 Q1 | 1.7 Billion ILS | 1.14% |
| 2015 FY | 1.53 Billion ILS | -9.17% |
| 2015 Q4 | 1.53 Billion ILS | -2.72% |
| 2015 Q3 | 1.57 Billion ILS | 0.46% |
| 2015 Q2 | 1.56 Billion ILS | -8.1% |
| 2014 Q2 | 2.52 Billion ILS | 19.69% |
| 2014 FY | 1.68 Billion ILS | -12.17% |
| 2014 Q1 | 2.1 Billion ILS | 9.82% |
| 2014 Q4 | 1.68 Billion ILS | -20.75% |
| 2014 Q3 | 2.12 Billion ILS | -15.68% |
| 2013 Q1 | 2.29 Billion ILS | 31.08% |
| 2013 Q2 | 2.37 Billion ILS | 3.52% |
| 2013 Q3 | 2.11 Billion ILS | -11.1% |
| 2013 FY | 1.92 Billion ILS | 9.83% |
| 2013 Q4 | 1.92 Billion ILS | -8.95% |
| 2012 Q4 | 1.74 Billion ILS | 0.0% |
| 2012 FY | 1.74 Billion ILS | 39.89% |
| 2011 FY | 1.25 Billion ILS | -8.32% |
| 2010 FY | 1.36 Billion ILS | 45.67% |
| 2009 FY | 936.32 Million ILS | 119.83% |
| 2008 FY | 425.92 Million ILS | 1.3% |
| 2007 FY | 420.47 Million ILS | 226.5% |
| 2006 FY | 128.78 Million ILS | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Matricelf Ltd | 39.49 Million ILA | -301.038% |